Table 2. Summary of adverse events.
Study | Skin discoloration | Puncture-site hematoma | Miscellaneous |
---|---|---|---|
Okuno et al 6 | 4/72, 0.1% | 12/72, 0.2% | 0 |
Bagla et al 11 | 13/20, 65.0% | 1/20, 0.1% | a 2/20, 0.1% |
Lee et al 7 | 3/45, 0.1% | 5/45, 0.1% | b 1/45, 0.02% |
Landers et al 14 | 0 | 1/10, 0.1% | 0 |
Little et al 15 | 4/38, 0.1% | 1/38, 0.02% | 0 |
Toe numbness.
Fever.